ThaiPR.NET https://www.thaipr.net/tag/astrazeneca Press Release Distribution Center of Thailand Fri, 10 Apr 2026 17:30:46 +0700 hourly 1 https://wordpress.org/?v=6.1.1 <![CDATA[AstraZeneca Thailand wins Top Employer Award 2023 for the third year in a row,reaffirming its position as a great place to work]]> https://www.thaipr.net/en/business_en/3293908 Mon, 23 Jan 2023 15:06:55 +0700 business_en https://www.thaipr.net/en/business_en/3293908 AstraZeneca (Thailand) Ltd., has won the Top Employer Award 2023 in Thailand from the Top Employers Institute for the third consecutive year, emphasising its position as a “Great Place to Work” and demonstrating its unwavering commitment to promoting and fostering a positive work environment. Over the years, AstraZeneca Thailand values Inclusion and Diversity (I&D) by […]

The post AstraZeneca Thailand wins Top Employer Award 2023 for the third year in a row,reaffirming its position as a great place to work appeared first on ThaiPR.NET.

]]> <![CDATA[AstraZeneca launches “Safeguard Our Cherished Moments” campaign in Thailand to raise awareness of the importance of enhancing immunity for vulnerable groups]]> https://www.thaipr.net/en/business_en/3281789 Fri, 16 Dec 2022 14:54:45 +0700 business_en https://www.thaipr.net/en/business_en/3281789 AstraZeneca (Thailand) Ltd. reaffirms its commitment to increase healthcare access and make healthcare systems more sustainable and resilient for the Thai community with the launch of the “Safeguard Our Cherished Moments” campaign. The campaign aims to raise public awareness and emphasise the importance of immunity during the COVID-19 period. Despite the downgrade of COVID-19 to […]

The post AstraZeneca launches “Safeguard Our Cherished Moments” campaign in Thailand to raise awareness of the importance of enhancing immunity for vulnerable groups appeared first on ThaiPR.NET.

]]> <![CDATA[AstraZeneca’s long-acting antibody (LAAB) combination granted conditional marketing approval for the treatment of COVID-19 in Thailand]]> https://www.thaipr.net/en/health_en/3260486 Wed, 02 Nov 2022 15:11:33 +0700 health_en https://www.thaipr.net/en/health_en/3260486 AstraZeneca’s AZD7442 (tixagevimab and cilgavimab), a long-acting antibody combination (LAAB), has been granted conditional marketing approval in Thailand for the treatment of mild to moderate COVID-19 in adults and adolescents (12 years of age and older weighing at least 40 kg). This approval is in addition to the conditional marketing approval granted to LAAB by […]

The post AstraZeneca’s long-acting antibody (LAAB) combination granted conditional marketing approval for the treatment of COVID-19 in Thailand appeared first on ThaiPR.NET.

]]> <![CDATA[AstraZeneca announces Evusheld long-acting antibody combination approved in the EU for the pre-exposure prophylaxis (prevention) of COVID-19 in a broad population]]> https://www.thaipr.net/en/health_en/3173568 Mon, 28 Mar 2022 16:00:00 +0700 health_en https://www.thaipr.net/en/health_en/3173568 AstraZeneca’s Evusheld (tixagevimab co-packaged with cilgavimab), a long-acting antibody combination, has been granted marketing authorisation in the European Union (EU) for the pre-exposure prophylaxis (prevention) of COVID-19 in a broad population of adults and adolescents aged 12 years and older weighing at least 40 kg. The full company announcement is available here. The approval by […]

The post AstraZeneca announces Evusheld long-acting antibody combination approved in the EU for the pre-exposure prophylaxis (prevention) of COVID-19 in a broad population appeared first on ThaiPR.NET.

]]> <![CDATA[AstraZeneca progresses Ambition Zero Carbon programme with Honeywell partnership to develop next-generation respiratory inhalers]]> https://www.thaipr.net/en/business_en/3171944 Thu, 24 Mar 2022 10:20:43 +0700 business_en https://www.thaipr.net/en/business_en/3171944 AstraZeneca and Honeywell will partner to develop next-generation respiratory inhalers using the propellant HFO-1234ze, which has up to 99.9% less Global Warming Potential (GWP) than propellants currently used in respiratory medicines.1 This announcement coincides with the publication of the Company’s annual Sustainability Report and demonstrates progress on its flagship sustainability programme, Ambition Zero Carbon. The […]

The post AstraZeneca progresses Ambition Zero Carbon programme with Honeywell partnership to develop next-generation respiratory inhalers appeared first on ThaiPR.NET.

]]> <![CDATA[Girls Take Over: AstraZeneca Thailand shows commitment to gender equality and female representation]]> https://www.thaipr.net/en/general_en/3118154 Fri, 05 Nov 2021 11:05:53 +0700 general_en https://www.thaipr.net/en/general_en/3118154 In celebration of International Day of the Girl, AstraZeneca’s Young Health Programme (YHP) virtually joins the global #GirlsTakeOver activity, a Plan International initiative, to promote inclusion and draw attention to the obstacles faced by young women in Thailand. As a science-led company, AstraZeneca is passionate about inspiring and advancing the next generation of women. To […]

The post Girls Take Over: AstraZeneca Thailand shows commitment to gender equality and female representation appeared first on ThaiPR.NET.

]]>